GTC Biotherapeutics (fka GTCB)

[jessellivermore]

IMHO I find the pathophysiology very logical, very compelling and very exciting, not just from a stock market point of view but in terms of the number of people which may benefit if this proves as important as it appears.

Also there is little reason to believe the mechinisms in cardiac ischemia are any different.